Articles in Autoimmune Diseases
The Food and Drug Administration (FDA) panel will vote Wednesday on whether Amgen’s drug, NPLATE, provides enough benefit to counteract the side effects associated with its use. NPLATE is intended to treat Idiopathic Thrombocytopenic Purpura …










